ACC 2016:请不要剥夺临终患者停用ICD的权利

2016-03-25 Seven L 译 MedSci原创

在芝加哥举行的第65届美国心脏病学会科学会议称,许多植入了心律转复除颤器(ICD)的患者都不知道这个装置是可以停用的,以避免生命的最后时刻,装置导致的痛苦的冲击。Silvia del Castillo博士和同事对243名植入ICD的患者进行了研究,虽然大多数患者能认识到自己使用ICD的原因和装置的功能,但是只有64%的患者晓得ICD引发的冲击是十分痛苦的。此外,68%的患者认为,室性心动过速时冲击

在芝加哥举行的第65届美国心脏病学会科学会议指出,许多植入了心律转复除颤器(ICD)的患者都不知道这个装置是可以停用的,这可以避免生命的最后时刻因装置导致的痛苦冲击。

Silvia del Castillo博士和同事对243名植入ICD的患者进行了研究,虽然大多数患者能认识到自己使用ICD的原因和装置的功能,但是只有64%的患者晓得ICD引发的冲击是十分痛苦的。此外,68%的患者认为,室性心动过速时冲击是不可避免的,还有21%的患者觉得停用装置就会立刻发生心脏骤停。只有38%的患者知道与医生交流后可以决定是否停用该装置,还有37%的患者知道停用ICD在伦理上是合理的,并且也被心血管学会所推荐。

Del Castillo说:“如果医生不给患者提供关于ICD停用的足够信息,或者直到生命的最后几个小时才就该问题展开对话,那么将会削弱患者做出决定的权利。”

其同事Dilek Yilmaz等人对328名ICD患者进行的研究发现,73%的患者知道ICD是可以停用的,64%的患者知道冲击的风险,只有12%的患者与医生交谈过这些主题。

研究并没有发现对ICD认识上的性别差异或教育水平差异。

Yilmaz说:“作为一名医生,如果不和患者讨论‘临终计划’,那就是剥夺了患者和平死亡的权利和机会。”

原始出处:

Studies Find Patients Uniformed About ICD Shocks at End of Life.Mar 23, 2016


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1860464, encodeId=d20c1860464e8, content=<a href='/topic/show?id=d064933e0b' target=_blank style='color:#2F92EE;'>#ICD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9337, encryptionId=d064933e0b, topicName=ICD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87f580, createdName=yilong5287542, createdTime=Sun Apr 03 11:33:00 CST 2016, time=2016-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325208, encodeId=8b15132520810, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sun Mar 27 10:33:00 CST 2016, time=2016-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570810, encodeId=2e7a15e0810fb, content=<a href='/topic/show?id=ace42309edc' target=_blank style='color:#2F92EE;'>#临终#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23097, encryptionId=ace42309edc, topicName=临终)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d35015719835, createdName=bbjsj_1984, createdTime=Sun Mar 27 10:33:00 CST 2016, time=2016-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=73860, encodeId=7f37e38609a, content=临终关怀还是需要的, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160414/IMG570FBE7A07E895161.jpg, createdBy=681a1704705, createdName=田田7760, createdTime=Sat Mar 26 17:50:00 CST 2016, time=2016-03-26, status=1, ipAttribution=)]
    2016-04-03 yilong5287542
  2. [GetPortalCommentsPageByObjectIdResponse(id=1860464, encodeId=d20c1860464e8, content=<a href='/topic/show?id=d064933e0b' target=_blank style='color:#2F92EE;'>#ICD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9337, encryptionId=d064933e0b, topicName=ICD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87f580, createdName=yilong5287542, createdTime=Sun Apr 03 11:33:00 CST 2016, time=2016-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325208, encodeId=8b15132520810, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sun Mar 27 10:33:00 CST 2016, time=2016-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570810, encodeId=2e7a15e0810fb, content=<a href='/topic/show?id=ace42309edc' target=_blank style='color:#2F92EE;'>#临终#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23097, encryptionId=ace42309edc, topicName=临终)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d35015719835, createdName=bbjsj_1984, createdTime=Sun Mar 27 10:33:00 CST 2016, time=2016-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=73860, encodeId=7f37e38609a, content=临终关怀还是需要的, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160414/IMG570FBE7A07E895161.jpg, createdBy=681a1704705, createdName=田田7760, createdTime=Sat Mar 26 17:50:00 CST 2016, time=2016-03-26, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1860464, encodeId=d20c1860464e8, content=<a href='/topic/show?id=d064933e0b' target=_blank style='color:#2F92EE;'>#ICD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9337, encryptionId=d064933e0b, topicName=ICD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87f580, createdName=yilong5287542, createdTime=Sun Apr 03 11:33:00 CST 2016, time=2016-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325208, encodeId=8b15132520810, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sun Mar 27 10:33:00 CST 2016, time=2016-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570810, encodeId=2e7a15e0810fb, content=<a href='/topic/show?id=ace42309edc' target=_blank style='color:#2F92EE;'>#临终#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23097, encryptionId=ace42309edc, topicName=临终)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d35015719835, createdName=bbjsj_1984, createdTime=Sun Mar 27 10:33:00 CST 2016, time=2016-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=73860, encodeId=7f37e38609a, content=临终关怀还是需要的, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160414/IMG570FBE7A07E895161.jpg, createdBy=681a1704705, createdName=田田7760, createdTime=Sat Mar 26 17:50:00 CST 2016, time=2016-03-26, status=1, ipAttribution=)]
    2016-03-27 bbjsj_1984
  4. [GetPortalCommentsPageByObjectIdResponse(id=1860464, encodeId=d20c1860464e8, content=<a href='/topic/show?id=d064933e0b' target=_blank style='color:#2F92EE;'>#ICD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9337, encryptionId=d064933e0b, topicName=ICD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87f580, createdName=yilong5287542, createdTime=Sun Apr 03 11:33:00 CST 2016, time=2016-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325208, encodeId=8b15132520810, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sun Mar 27 10:33:00 CST 2016, time=2016-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570810, encodeId=2e7a15e0810fb, content=<a href='/topic/show?id=ace42309edc' target=_blank style='color:#2F92EE;'>#临终#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23097, encryptionId=ace42309edc, topicName=临终)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d35015719835, createdName=bbjsj_1984, createdTime=Sun Mar 27 10:33:00 CST 2016, time=2016-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=73860, encodeId=7f37e38609a, content=临终关怀还是需要的, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160414/IMG570FBE7A07E895161.jpg, createdBy=681a1704705, createdName=田田7760, createdTime=Sat Mar 26 17:50:00 CST 2016, time=2016-03-26, status=1, ipAttribution=)]
    2016-03-26 田田7760

    临终关怀还是需要的

    0

相关资讯

JAMA:心梗后患者ICD置入率和死亡风险

置入心脏复律除颤器(ICD)不被推荐用于心肌梗死(MI)40天以内的患者,因此在MI后过渡期管理期间可能不考虑予患者置入ICD治疗。美国学者近期在低射血分数(EF)老年MI患者中评估了ICD置入率和与其相关的死亡率,结果表明,在上述人群中,虽然ICD置入与2年时患者较低的校正死亡风险有关,但不到1/10的适宜患者在MI后1年内接受了ICD置入。相关论

JACC:ICD植入后患者的LVEF变化如何影响死亡和心源性猝死?

初级预防植入式心脏除颤器(ICD)的心脏衰竭患者随着时间的变化可能会遇到左心室射血分数(LVEF)改善的情况。然而,目前还不清楚LVEF的改善如何影响后续的死亡和心源性猝死的风险。    这项研究旨在评估植入ICD后LVEF的变化以及这些变化对并在后续的死亡和ICD电击的影响。    研究人员进行了包括538例患者的前瞻性队列研究,这些患

李剑明教授:ESC室性心律失常和心脏性猝死新指南将新在哪儿?

2015欧洲心脏病学会年会(ESC2015)专题报道2015 ESC临床实践指南(2015 ESC Clinical Practice Guidelines)。该专场将公布有关室性心律失常和心脏性猝死、肺动脉高压、非ST段抬高型急性冠脉综合征、心包疾病和感染性心内膜炎的5大指南更新。今天就从《室性心律失常和心脏性猝死指南》开始,赶快来先睹为快吧!上版ACC/AHA/ESC《室性心律失常和心脏性猝死

BMJ:起搏器电池寿命太短怎么办?

想象一下,花了3000英镑买了一块新手表但是不能充电也不能更换电池。尽管手表的电池预计可维持至少10年,但是6年之后你觉得它太单调或不好用,即使它还能使用1年以上,别人劝你更换手表,你会换么? 这也反映了所有安装心脏植入电子设备如心脏起搏器、埋藏式心脏复律除颤器(ICD)的患者的处境。但对他们来说更换电池会增加他们感染等并发症的风险,这会给他们带来生命威胁。 超过一半的患者因为心脏起搏器电池没电需

ESC 2015:新版室性心律失常和心脏性猝死指南重要更新抢先速看

8月29日,ESC对室性心律失常和心脏性猝死指南进行了重要更新,新版指南最新发表在European Heart Journal和ESC网站,这是继2006年版欧洲/美国的欧洲指南最新更新。这一指南旨在预防室性心律失常患者心源性猝死的发生。1.DNA分析应作为中青年猝死者验尸报告中的一个基本组成 明确中青年猝死者的遗传因素情况有助于快速诊断猝死的原因,对防止亲属中再次发生猝死有益。指南的制

李广平:ICD/CRT-P/CRT-D植入指征的变化与临床个体化

一、ICD/CRT-P/CRT-D植入指征的变化 早在2006年中华医学会心电生理与起搏分会《心脏再同步化治疗慢性心力衰竭的建议》和ACC/AHA/HRS 2008年《心脏节律异常器械治疗指南CRT治疗建议》认为,在最佳药物治疗基础上NYHA心功能Ⅰ或Ⅱ级的心衰患者,在植入永久起搏器或ICD时,若预 期需长时期心室起搏可考虑植入CRT,但是仅作为Ⅱb类指征(证据水平:C)。2